Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marsh & McLennan Companies, Inc., doing business as Marsh McLennan, files reports with the US Securities and Exchange Commission as a public company with common stock listed on the New York Stock Exchange. This SEC filings page for MMC provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other filings that document material events, governance changes and financial reporting updates.
Recent Form 8-K filings illustrate the types of information Marsh McLennan reports. One filing describes amendments and restatements of the company’s bylaws, noting updates to align with changes in the Delaware General Corporation Law, revisions to advance notice provisions for director nominations and stockholder proposals, clarification of voting standards for matters submitted to stockholders, and clarification of the authority of the chair of stockholder meetings. Other 8-K filings disclose quarterly financial results, conference calls to discuss those results, and board-level changes such as the appointment of an independent director to the Board and Audit Committee.
Filings also show details about Marsh McLennan’s capital structure and listing status, including the registration of its common stock, par value $1.00 per share, and the trading symbols under which it is listed on the New York Stock Exchange. Investors can review these filings to understand how Marsh McLennan communicates material events, corporate governance changes and financial information.
On Stock Titan, Marsh McLennan’s SEC filings are paired with AI-powered tools that can help explain the contents of lengthy documents, highlight key sections, and surface items such as current reports, annual and quarterly reports, and disclosures about governance or board changes. This makes it easier to navigate Marsh McLennan’s regulatory history, track updates over time, and connect specific filings to news and other public communications about the company.
Marsh & McLennan Companies reported lower profitability for the quarter ended March 31, 2026, despite higher revenue. Revenue rose to $7.60 billion from $7.06 billion, driven by both Risk & Insurance Services and Consulting.
Operating income declined to $1.75 billion from $2.01 billion, largely due to a $425 million legal liability and related costs recorded in Risk & Insurance Services for Greensill-related proceedings in Australia. Net income attributable to the company fell to $1.15 billion, with diluted EPS down to $2.36 from $2.79.
Operating cash flow was a $688 million outflow, reflecting seasonal working capital movements and compensation payments. The company continued returning capital, repurchasing 4.2 million shares for $750 million and declaring dividends of $1.80 per share for the period, while restructuring under its three‑year “Thrive” program added $45 million of charges.
Marsh & McLennan Companies reported solid first quarter 2026 results with continued growth in its core businesses but a notable legal charge affecting GAAP earnings.
Revenue reached $7.6 billion, up 8% from the first quarter of 2025, or 4% on an underlying basis after adjusting for currency and deal effects. Risk & Insurance Services revenue rose 6% to $5.1 billion, while Consulting revenue increased 11% to $2.6 billion, both showing mid‑single‑digit underlying growth.
GAAP operating income declined 12% to $1.8 billion, driven by a $425 million charge related to the Greensill litigation. Excluding this and other noteworthy items and intangible amortization, adjusted operating income increased 8% to $2.4 billion, with an adjusted operating margin of 31.8%.
Net income attributable to the company was $1.1 billion, with diluted GAAP EPS of $2.36 versus $2.79 a year earlier. Adjusted EPS rose 8% to $3.29 from $3.06, reflecting underlying earnings growth despite the litigation charge.
The company continued capital returns, repurchasing approximately 4.2 million shares for $750 million and paying dividends. It also issued and repaid $600 million of senior notes. Management highlighted stable growth across geographies and segments, including 5% underlying revenue growth in International Marsh Risk and 5% underlying growth at Mercer.
Marsh & McLennan Companies appointed Mark McGivney as Executive Vice President, Chief Operating Officer & Chief Financial Officer, effective April 15, 2026. This expands his role beyond his long-standing position as CFO at Marsh.
In connection with the promotion, his annual base salary will be $1,250,000, with an annual bonus target of $3,450,000 starting with the 2026 performance year and a long-term incentive award target of $6,300,000 beginning with the 2027 grant cycle. He will also receive a $10 million grant of stock units on May 1, 2026, vesting in three equal annual installments starting May 15, 2027. The company highlights his nearly 20-year tenure and prior senior finance and operating roles across the firm.
Marsh & McLennan Companies executive Edward Francis Moynihan, President & CEO of Oliver Wyman, filed an initial ownership report showing direct equity interests in the company. He holds 9,121 shares of common stock, plus 8,867 restricted stock units that convert into common stock on a 1-for-1 basis.
He also holds multiple tranches of stock options over common stock, with exercise prices ranging from $73.20 to $230.29 per share and expiration dates between February 2027 and February 2035, reflecting equity awards granted annually from 2017 through 2025 that vest in four equal yearly installments.
Marsh & McLennan Companies reported that Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 5,766 restricted stock units on common stock as equity compensation. The units were granted at no cash cost and convert into common stock on a 1-for-1 basis.
These restricted stock units are scheduled to vest on April 15, 2029. Following this grant, Studer holds 5,766 restricted stock units directly under this award, reflecting a routine long-term incentive grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies has issued its 2026 proxy statement for a virtual annual meeting on May 21, 2026, seeking shareholder approval to elect 13 directors, hold an advisory vote on executive pay, and ratify Deloitte & Touche as auditor. Marsh reports 2025 revenue of $27.0 billion, up 10% on a GAAP basis with 4% underlying revenue growth, GAAP EPS up 3% and adjusted EPS up 9%. GAAP operating income grew 7% and adjusted operating income 11%, with adjusted margin expanding for the 18th consecutive year. Five-year annualized TSR of 11.3% beat the S&P 500 Equal Weight Index but trailed the S&P 500, while 2025 TSR was -11.3%. The company returned capital through a record $2.0 billion share repurchase and about $1.7 billion in dividends, and invested roughly $850 million in 20 acquisitions that added $255 million of revenue. A new three-year “Thrive” program is expected to generate approximately $400 million in annualized savings. Executive bonuses were set above target and 2023 PSU awards paid out at 176% of target based on 12.7% three-year annualized adjusted EPS growth and relative TSR.
Marsh & McLennan Cos Inc: The Vanguard Group filed Amendment No. 10 to its Schedule 13G/A reporting that it beneficially owns 0 shares of Marsh & McLennan Common Stock. The filing explains an internal realignment effective January 12, 2026 and reliance on SEC Release No. 34-39538 to disaggregate certain subsidiaries' holdings. The form is signed by Ashley Grim, Head of Global Fund Administration on 03/27/2026.
Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported the vesting and conversion of restricted stock units into common stock. On March 15, 2026, 1,228 RSUs converted into 1,228 shares of common stock on a 1-for-1 basis. Of these, 627 shares were withheld by the company at $172.15 per share to cover applicable taxes, leaving Tomlinson with additional net shares and 4,256 common shares held directly after the transactions. No remaining derivative positions are shown in this filing, indicating a routine compensation-related vesting with tax withholding rather than an open-market trade.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported an open-market sale of common stock. On March 11, 2026, he sold 2,362 shares at an average price of $173.6101 per share. After the sale, he directly held 7,978 shares, with an additional 1,819.885 shares held indirectly through the MMC 401(k) Savings & Investment Plan.